Everand Logo

Welcome to Everand!

  • NPR

    Moderna's COVID-19 Vaccine Shines In Clinical Trial

    The vaccine is nearly 95% effective in preventing illness, according to an interim analysis of a clinical test involving 30,000 people.
    by Joe Palca Nov 16, 2020 3 minutes
    Clinical data for Moderna's COVID-19 vaccine showed it was nearly 95% effective in preventing disease, according to an interim analysis described in a company release Monday.

    A second COVID-19 vaccine now also appears highly effective in preventing illness following exposure to the virus that causes the disease.

    The biotech company Moderna Inc. said Monday that its experimental vaccine was 94.5% effective in preventing disease, according to an analysis of its clinical trial.

    The news comes a week after Pfizer and BioNTech said their vaccine was more than 90% effective.

    The results for both vaccines come from interim analyses of large

    You’re reading a preview, subscribe to read more.

    More from NPR

    NPR2 min read
    A Federal Judge Temporarily Halts U.S. Plan To Lower Credit Card Late Fees To $8
    The temporary injunction imposed by Judge Mark Pittman in the Northern District of Texas is a win for the big banks and major credit card companies. The plan was set to go into effect next week.
    NPR17 min readAmerican Government
    What Did Trump Say? Explaining The Former President's Favorite Talking Points
    Former President Donald Trump continues to ratchet up his rhetoric on the campaign trail, but if someone doesn't follow Trump all the time, decoding his meaning can get confusing. We're here to help.
    NPR3 min read
    WNBA Teams Will Travel On Chartered Flights For The Next 2 Seasons, The League Says
    Before, teams could travel on chartered flights during the postseason and for back-to-back games in the regular season. Many players said the change will make recovery easier and make them feel safer.

    Related Books & Audiobooks